Literature DB >> 10893760

[Analysis of the needs for diagnosis and therapy of tobacco dependence in Austria].

E Groman1, P Bayer, U Kunze, A Schmeiser-Rieder, R Schoberberger.   

Abstract

In Austria we find 2.3 Mio. tobacco users (29% of the population). 1.3 Mio. are dissonant smokers, they want to stop (18%) or reduce (37%) tobacco consumption. The assumption that 10% of dissonant smokers (130,000 tobacco users) need a diagnosis and therapy leads to a bottleneck: 130,000 patients versus 20 therapists. Demanded consequences of this disproportion are training for health-care workers, implementation of diagnosis and treatment, financing and refunding. Diagnosis and therapy of tobacco dependence should be offered in highly specialised organisations such as the prototypical Nicotine Institute in Vienna, in hospitals and in primary health care.

Entities:  

Mesh:

Year:  2000        PMID: 10893760

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  5 in total

1.  [Smoking cessation must be professionalized].

Authors:  Michael Kunze; Ernest Groman
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

2.  [Smoking].

Authors:  Michael Kunze; Ernest Groman
Journal:  Wien Med Wochenschr       Date:  2009

3.  "A heart for Vienna"--the prevention program for the big city. Blue-collar workers as a special target group.

Authors:  Thomas Dorner; J George Fodor; Doris Allichhammer; Ingrid Kiefer; Kitty Lawrence; Monika Slovinec D'Angelo; Ursula Huebel; Barbara Strunz; Annemarie Ohnoutka; Gernot Antes; Hannes Schmidl; Michael Kunze; Anita Rieder
Journal:  Wien Med Wochenschr       Date:  2006-10

4.  [Outpatient smoking cessation: a report on 3,260 cases].

Authors:  Ernest Groman; Astrid Riemerth; Andrea Steiner-Ringl; Irene Veitsmeier; Armin Kroat; Ulrike Kroat; Gerda Bernhard
Journal:  Wien Med Wochenschr       Date:  2009

5.  [The prevalence of COPD in Austria--the expected change over the next decade].

Authors:  Natalie Firlei; Bernd Lamprecht; Lea Schirnhofer; Bernhard Kaiser; Michael Studnicka
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.